These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11246059)

  • 1. Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-converting enzyme inhibitor dose at discharge.
    McDonald K; Ledwidge M; Cahill J; Kelly J; Quigley P; Maurer B; Begley F; Ryder M; Travers B; Timmons L; Burke T
    Eur J Heart Fail; 2001 Mar; 3(2):209-15. PubMed ID: 11246059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specialist nurse supervised in-hospital titration to target dose ACE inhibitor--is it safe and feasible in a community heart failure population?
    Ryder M; Travers B; Timmons L; Ledwidge M; McDonald K
    Eur J Cardiovasc Nurs; 2003 Sep; 2(3):183-8. PubMed ID: 14622625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the first dose hypotensive effects of captopril and perindopril in patients with heart failure.
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):501-6. PubMed ID: 11916359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure.
    Luzier AB; Forrest A; Adelman M; Hawari FI; Schentag JJ; Izzo JL
    Am J Cardiol; 1998 Aug; 82(4):465-9. PubMed ID: 9723634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group.
    Vítovec J; Spinar J
    Eur J Heart Fail; 2000 Sep; 2(3):299-304. PubMed ID: 10938492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
    Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure.
    McDermott MM; Lee P; Mehta S; Gheorghiade M
    Clin Cardiol; 1998 Apr; 21(4):261-8. PubMed ID: 9562936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care?
    Ledwidge M; Barry M; Cahill J; Ryan E; Maurer B; Ryder M; Travers B; Timmons L; McDonald K
    Eur J Heart Fail; 2003 Jun; 5(3):381-9. PubMed ID: 12798838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
    Cleland JG; Tendera M; Adamus J; Freemantle N; Polonski L; Taylor J;
    Eur Heart J; 2006 Oct; 27(19):2338-45. PubMed ID: 16963472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
    Song HM; Zhang J; Deng B; Luo M
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1737-40. PubMed ID: 16253158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
    Sanam K; Bhatia V; Bajaj NS; Gaba S; Morgan CJ; Fonarow GC; Butler J; Deedwania P; Prabhu SD; Wu WC; White M; Love TE; Aronow WS; Fletcher RD; Allman RM; Ahmed A
    Am J Med; 2016 Oct; 129(10):1067-73. PubMed ID: 27262781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perindopril: in congestive heart failure.
    Simpson D; Noble S; Goa KL
    Drugs; 2002; 62(9):1367-77; discussion 1378-9. PubMed ID: 12076191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure.
    Chen YT; Wang Y; Radford MJ; Krumholz HM
    Am Heart J; 2001 Mar; 141(3):410-7. PubMed ID: 11231438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitor use in elderly patients hospitalized with heart failure and left ventricular systolic dysfunction.
    Rangaswamy C; Finn JI; Koelling TM
    Cardiology; 2005; 103(1):17-23. PubMed ID: 15528896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial.
    Cice G; Di Benedetto A; D'Isa S; D'Andrea A; Marcelli D; Gatti E; Calabrò R
    J Am Coll Cardiol; 2010 Nov; 56(21):1701-8. PubMed ID: 21070920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?
    Richardson A; Tolley E; Hartmann J; Reedus J; Bowlin B; Finch C; Sands CW; Self T
    Respir Med; 2016 Oct; 119():135-140. PubMed ID: 27692135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poles apart, but are they the same? A comparative study of Australian and Scottish patients with chronic heart failure.
    Stewart S; Blue L; Capewell S; Horowitz JD; McMurray JJ
    Eur J Heart Fail; 2001 Mar; 3(2):249-55. PubMed ID: 11246064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.